Yazla, E. Et Al. 2023. Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.38, no.6 , 394-401.

Yazla, E., Cetin, I., & KAYADİBİ, H., (2023). Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.38, no.6, 394-401.

Yazla, Ece, Ihsan Cetin, And HÜSEYİN KAYADİBİ. "Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study," INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.38, no.6, 394-401, 2023

Yazla, Ece Et Al. "Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study." INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.38, no.6, pp.394-401, 2023

Yazla, E. Cetin, I. And KAYADİBİ, H. (2023) . "Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study." INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol.38, no.6, pp.394-401.

@article{article, author={Ece Yazla Et Al. }, title={Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study}, journal={INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY}, year=2023, pages={394-401} }